Microparticles induce multifactorial resistance through oncogenic pathways independently of cancer cell type

31Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

Abstract

Multidrug resistance (MDR) is considered a multifactorial event that favors cancer cells becoming resistant to several chemotherapeutic agents. Numerous mechanisms contribute to MDR, such as P-glycoprotein (Pgp/ABCB1) activity that promotes drug efflux, overexpression of inhibitors of apoptosis proteins (IAP) that contribute to evasion of apoptosis, and oncogenic pathway activation that favors cancer cell survival. MDR molecules have been identified in membrane microparticles (MP) and can be transferred to sensitive cancer cells. By co-culturing MP derived from MDR-positive cells with recipient cells, we showed that sensitive cells accumulated Pgp, IAP proteins and mRNA. In addition, MP promoted microRNA transfer and NFκB and Yb-1 activation. Therefore, our results indicate that MP can induce a multifactorial phenotype in sensitive cancer cells. Microparticles promoted microRNA transfer and NFkB and Yb-1 oncogenic pathway activation. Microparticles can induce a multifactorial phenotype in sensitive cancer cells.

Cite

CITATION STYLE

APA

de Souza, P. S., Cruz, A. L. S., Viola, J. P. B., & Maia, R. C. (2015). Microparticles induce multifactorial resistance through oncogenic pathways independently of cancer cell type. Cancer Science, 106(1), 60–68. https://doi.org/10.1111/cas.12566

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free